logo
Select company
Select metric
22.58Enterprise Value over EBIT
VS
Market
39
Sector
41
Industry
35
History
100
$ 10.8Close
$ 6.56 - $ 12.79 52-Week Range
Ticker Information

Ticker

ZVRA

Company Name

ZEVRA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ZEVRA THERAPEUTICS INC - Enterprise Value over EBIT Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ZVRA - EV/EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)Enterprise ValueEnterprise Value over EBIT
6/30/2025$ 29.88M$ 674.71M22.58
3/31/2025$ -66.78M$ 454.83M0
12/31/2024$ -82.79M$ 455.11M0
9/30/2024$ -79.01M$ 468.12M0
6/30/2024$ -61.6M$ 388.01M0
3/31/2024$ -48.82M$ 211.96M0
12/31/2023$ -44.55M$ 224.8M0
9/30/2023$ -39.19M$ 160.91M0
6/30/2023$ -32.29M$ 130.83M0
3/31/2023$ -52.05M$ 121.66M0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ZEVRA THERAPEUTICS INC's latest trailing twelve months (TTM) EV/EBIT stands at 0.
  • Over the past 5 years, ZEVRA THERAPEUTICS INC's average EV/EBIT has been 133.61.
  • The median EV/EBIT for ZEVRA THERAPEUTICS INC during this period was 133.61
  • ZEVRA THERAPEUTICS INC reached its highest EV/EBIT over the past 5 years at 244.63.
  • The lowest EV/EBIT recorded by ZEVRA THERAPEUTICS INC in the same timeframe 22.58

ZEVRA THERAPEUTICS INC's EV/EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EV/EBIT Benchmarks
CompanyEV/EBIT
EYPT : EYEPOINT PHARMACEUTICALS INC -TBPH : THERAVANCE BIOPHARMA INC 9.12SAGE : SAGE THERAPEUTICS INC -MGTX : MEIRAGTX HOLDINGS PLC -LXRX : LEXICON PHARMACEUTICALS INC -NKTR : NEKTAR THERAPEUTICS -KURA : KURA ONCOLOGY INC -GOSS : GOSSAMER BIO INC -NRIX : NURIX THERAPEUTICS INC -SNDX : SYNDAX PHARMACEUTICALS INC -

Definition of Enterprise Value over EBIT

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
EV / EBIT
(=) EV/EBIT
EV/EBIT for ZEVRA THERAPEUTICS INC is calculated as follows: EV [ $ 104.59M ] / EBIT [ $ -8.95M ]
(=) EV/EBIT [ 0 ]

ZVRA - Enterprise Value over EBIT, Last 5 years

22.58

Minimum

Jun 30, 2025

244.63

Maximum

Mar 31, 2022

133.61

Average

133.61

Median

EV/EBIT Benchmark Analysis

The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.91 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
filtered constituents2.25K
min0.05
max62.03
average19.91
median16.78
std12.32